A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer

A Prospective Quality of Life Study in Men With Clinically Localized Prostate Carcinoma Treated With Different Treatment Modalities

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00777452

Enrollment

Registered

2008-10-22

Start date

2005-03-31

Completion date

2007-12-31

Last updated

2008-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

quality of life, localized prostate cancer, FACT-P

Brief summary

to prospectively assess the health-related quality of life (HRQOL) changes during the first year after different treatment modalities for localized prostate cancer.

Detailed description

Quality of life is of great concern to patients considering treatment options for prostate cancer. Patients with clinically localized prostate cancer treated with active surveillance, radical prostatectomy, external radiotherapy and high intensity focused ultrasound were included. All men completed the questionnaires of Functional Assessment of Cancer Therapy-Prostate (FACT-P) (version 4), International Prostate Symptom Score (IPSS) and International Index of Erectile Function (IIEF) before treatment and 1, 3, 6, 12 months after treatment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

43 Years to 82 Years

Healthy volunteers

Inclusion criteria

* patients diagnosed with clinically localized prostate cancer

Exclusion criteria

* patients with another malignancies

Design outcomes

Primary

Measure	Time frame
Health-related quality of life changes over time	12 months after treatment

Secondary

Measure	Time frame
urinary symptom score and erectile function over time	12 months after treatment

Countries

South Korea

Outcome results